| Target Population: Adults (18+ years) with type 2 diabetes mellitus. | |
| Function: As a GLP-1 receptor agonist, it mimics the GLP-1 hormone to increase insulin, decrease glu | |
| Cardiovascular Benefit: Reduced risk of heart attack, stroke, and cardiovascular death in adults wit | |
| Administration: Take one 14 mg tablet once daily on an empty stomach, upon waking, with a small sip |
Rybelsus (semaglutide) 14 mg tablets are a daily oral medication used alongside diet and exercise to improve glycemic control (blood sugar and HbA1c levels) in adults with type 2 diabetes. The 14 mg dose is typically the highest maintenance dose for greater blood sugar control, and it is also used to reduce the risk of major cardiovascular events—such as heart attack, stroke, or death—in adults with type 2 diabetes.